Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: Natural history and function of menin in tumorigenesis

Endocrine-Related Cancer

Volumn 21, Issue 3, 2014, Pages

  Pieterman, C R C ^a   Conemans, E B ^a   Dreijerink, K M A ^a   De Laat, J M ^a   Timmers, H Th M ^a   Vriens, M R ^a   Valk, G D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Duodenopancreatic NET; Epigenetics; Lung NET; MEN1; Menin; Multiple endocrine neoplasia type 1; Natural history; Neuroendocrine tumors; Pancreatic NET; Thymic NET

Indexed keywords

CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CARCINOID; CHROMOSOME 11Q; DUODENOPANCREATIC NEUROENDOCRONE TUMOR; EPIGENETICS; GASTRINOMA; GENETIC TRANSCRIPTION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; INSULINOMA; LOSS OF FUNCTION MUTATION; MEN1 GENE; MULTIPLE ENDOCRINE NEOPLASIA; ONCOGENE; REVIEW; THORACIC NEUROENDOCRINE TUMOR; TUMOR VOLUME; CELL TRANSFORMATION; DUODENUM TUMOR; METABOLISM; MULTIPLE CANCER; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PATHOLOGY; THORAX TUMOR;

MEN1 PROTEIN, HUMAN; ONCOPROTEIN;

CELL TRANSFORMATION, NEOPLASTIC; DUODENAL NEOPLASMS; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASMS, MULTIPLE PRIMARY; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; THORACIC NEOPLASMS;

EID: 84903587348     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0482     Document Type: Review

References (229)

1. Abe T, Sato M, Okumura T, Shioyama Y, Kiyoshima M, Asato Y, Saito H, Iijima T, Amemiya R & Nagai H 2008 FDG PET/CT findings of thymic carcinoid and bronchial carcinoid in a patient with multiple neuroendocrine neoplasia type 1. Clinical Nuclear Medicine 33 778-779. (doi:10.1097/RLU.0b013e318187efef)
2. Agarwal S & Jothi R 2012 Genome-wide characterization of menindependent H3K4me3 reveals a specific role for menin in the regulation of genes implicated in MEN1-like tumors. PLoS ONE 7 e37952. (doi:10.1371/journal. pone.0037952)
3. Agarwal S, Kester M, Debelenko L, Heppner C, Emmert-BuckM, Skarulis M, Doppman J, Kim Y, Lubensky I, Zhuang Z et al. 1997 Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Human Molecular Genetics 6 1169-1175. (doi:10.1093/hmg/6.7.1169) (Pubitemid 27308404)
4. Agarwal S, Guru S, Heppner C, Erdos M, Collins R, Park S, Saggar S, Chandrasekharappa S, Collins F, Spiegel A et al. 1999 Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96 143-152. (doi:10.1016/S0092-8674(00)80967-8) (Pubitemid 29044161)
5. Agarwal S, Mateo C & Marx S 2009 Rare germline mutations in cyclindependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. Journal of Clinical Endocrinology and Metabolism 94 1826-1834. (doi:10.1210/jc.2008-2083)
6. Aguayo S,Miller Y, Waldron JA Jr, Bogin R, SundayM, Staton G Jr, BeamW & King T Jr 1992 Brief report: Idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. New England Journal of Medicine 327 1285-1288. (doi:10.1056/NEJM199210293271806)
7. Anlauf M, Perren A, Meyer CL, Schmid S, Saremaslani P, Kruse ML, Weihe E, Komminoth P, Heitz PU & Kloppel G 2005 Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas. Gastroenterology 128 1187-1198. (doi:10.1053/j.gastro.2005.01.058) (Pubitemid 40712171)
8. Anlauf M, Garbrecht N, Henopp T, Schmitt A, Schlenger R, Raffel A, Krausch M, Gimm O, Eisenberger CF, Knoefel WT et al. 2006a Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World Journal of Gastroenterology 12 5440-5446. (Pubitemid 44501800)
9. Anlauf M, Schlenger R, Perren A, Bauersfeld J, Koch CA, Dralle H, Raffel A, Knoefel WT, Weihe E, Ruszniewski P et al. 2006b Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. American Journal of Surgical Pathology 30 560-574. (doi:10.1097/01.pas.0000194044.01104.25) (Pubitemid 44265008)
10. Anlauf M, Bauersfeld J, Raffel A, Koch CA, Henopp T, Alkatout I, Schmitt A, Weber A, Kruse M, Braunstein S et al. 2009 Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia. American Journal of Surgical Pathology 33 339-346. (doi:10.1097/PAS.0b013e3181874eca)
11. Bai F, Pei XH, Nishikawa T, Smith MD & Xiong Y 2007 p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors. Molecular and Cellular Biology 27 1495-1504. (doi:10.1128/MCB.01764-06) (Pubitemid 46239829)
12. Ballard HS, Fame B & Hartsock RJ 1964 Familial multiple endocrine adenoma-peptic ulcer complex. Medicine 43 481-516. (doi:10.1097/00005792- 196407000-00003)
13. Bartsch DK, Langer P, Wild A, Schilling T, Celik I, Rothmund M & Nies C 2000 Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 128 958-966. (doi:10.1067/msy.2000. 109727)
14. Bartsch DK, Fendrich V, Langer P, Celik I, Kann PH & Rothmund M 2005 Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Annals of Surgery 242 757-764 (discussion 764-766). (doi:10.1097/01.sla.0000189549.51913.d8)
15. Bertolino P, Radovanovic I, Casse H, Aguzzi A, Wang ZQ & Zhang CX 2003a Genetic ablation of the tumor suppressormenin causes lethality at midgestation with defects in multiple organs. Mechanisms of Development 120 549-560. (doi:10.1016/S0925-4773(03)00039-X) (Pubitemid 36623317)
16. Bertolino P, Tong WM, Herrera PL, Casse H, Zhang CX & Wang ZQ 2003b Pancreatic β-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Research 63 4836-4841. (Pubitemid 37022614)
17. Besson A, Dowdy SF & Roberts JM 2008 CDK inhibitors: cell cycle regulators and beyond. Developmental Cell 14 159-169. (doi:10.1016/j.devcel. 2008.01.013)
18. Biondi CA, Gartside MG, Waring P, Loffler KA, Stark MS, Magnuson MA, Kay GF & Hayward NK 2004 Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues. Molecular and Cellular Biology 24 3125-3131. (doi:10.1128/MCB.24.8.3125-3131.2004) (Pubitemid 38452058)
19. Boddaert G, Grand B, Le Pimpec-Barthes F, Cazes A, Bertagna X & Riquet M 2012 Bronchial carcinoid tumors causing Cushing's syndrome: more aggressive behavior and the need for early diagnosis. Annals of Thoracic Surgery 94 1823-1829. (doi:10.1016/j.athoracsur.2012.07.022)
20. Boers JE, den Brok JL, Koudstaal J, Arends JW & Thunnissen FB 1996 Number and proliferation of neuroendocrine cells in normal human airway epithelium. American Journal of Respiratory and Critical Care Medicine 154 758-763. (doi:10.1164/ajrccm.154.3.8810616) (Pubitemid 26327302)
21. Bosman FT, Carneiro F, Hruban RH & Theisse ND (Eds) 2010 In WHO Classification of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer (IARC).
22. Burgess JR, Greenaway TM, Parameswaran V, Challis DR, David R & Shepherd JJ 1998a Enteropancreatic malignancy associated with multiple endocrine neoplasia type 1: risk factors and pathogenesis. Cancer 83 428-434. (doi:10.1002/(SICI)1097-0142(19980801)83:3〈428::AID-CNCR10〉3.0.CO;2-Y) (Pubitemid 28354497)
23. Burgess JR, Greenaway TM & Shepherd JJ 1998b Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. Journal of Internal Medicine 243 465-470. (doi:10.1046/j.1365-2796.1998.00275.x) (Pubitemid 28312242)
24. Byström C, Larsson C, Blomberg C, Sandelin K, Falkmer U, Skogseid B, Oberg K, Werner S & Nordenskjöld M 1990 Localization of the MEN1 gene to a small region within chromosome 11q13 by deletionmapping in tumors. PNAS 87 1968-1972. (doi:10.1073/pnas.87.5.1968) (Pubitemid 120030884)
25. Cadiot G, Vuagnat A, Doukhan I, Murat A, Bonnaud G, Delemer B, Thiefin G, Beckers A, Veyrac M, Proye C et al. 1999 Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). Gastroenterology 116 286-293. (doi:10.1016/S0016-5085(99)70124-1)
26. Cao C, Yan TD, Kennedy C, Hendel N, Bannon PG & McCaughan BC 2011 Bronchopulmonary carcinoid tumors: long-term outcomes after resection. Annals of Thoracic Surgery 91 339-343. (doi:10.1016/j.athoracsur.2010.08.062)
27. Cardillo G, Rea F, Lucchi M, Paul MA, Margaritora S, Carleo F, Marulli G, Mussi A, Granone P & Graziano P 2012 Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients. Annals of Thoracic Surgery 94 241-245 (discussion 245-246). (doi:10.1016/j.athoracsur.2012.03.062)
28. Carty SE, Helm AK, Amico JA, Clarke MR, Foley TP, Watson CG & Mulvihill JJ 1998 The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 124 1106-1113 (discussion 1113-1114). (doi:10.1067/msy.1998.93107)
29. Cavaco BM, Domingues R, Bacelar MC, Cardoso H, Barros L, Gomes L, Ruas MM, Agapito A, Garrão A, Pannett AA et al. 2002 Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions. Clinical Endocrinology 56 465-473. (doi:10.1046/j.1365-2265. 2002.01505.x)
30. Chandrasekharappa SC, Guru S, Manickam P, Olufemi S, Collins F, Emmert-Buck M, Debelenko L, Zhuang Z, Lubensky I, Liotta L et al. 1997 Positional cloning of the gene for multiple endocrine neoplasiatype 1. Science 276 404-407. (doi:10.1126/science.276.5311.404)
31. Chi P, Allis CD & Wang GG 2010 Covalent histone modifications- miswritten, misinterpreted and mis-erased in human cancers. Nature Reviews. Cancer 10 457-469. (doi:10.1038/nrc2876)
32. Cougard P, Goudet P, Peix JL, Henry JF, Sarfati E, Proye C & Calender A 2000 Insulinomas in multiple endocrine neoplasia type 1. Report of a series of 44 cases by the Multiple Endocrine Neoplasia Study Group. Annales de Chirurgie 125 118-123. (doi:10.1016/S0001-4001(00)00112-4)
33. Crabtree JS, Scacheri PC, Ward JM, McNally SR, Swain GP, Montagna C, Hager JH, Hanahan D, Edlund H, Magnuson MA et al. 2003 Of mice and MEN1: insulinomas in a conditional mouse knockout. Molecular and Cellular Biology 23 6075-6085. (doi:10.1128/MCB.23.17.6075-6085.2003) (Pubitemid 37013087)
34. Crippa S, Zerbi A, Boninsegna L, Capitanio V, Partelli S, Balzano G, Pederzoli P, Di Carlo V & Falconi M 2012 Surgical management of insulinomas: short-and long-term outcomes after enucleations and pancreatic resections. Archives of Surgery 147 261-266. (doi:10.1001/archsurg.2011.1843)
35. Crona J, Bjorklund P, Welin S, Kozlovacki G, Oberg K & Granberg D 2013 Treatment, prognostic markers and survival in thymic neuroendocrine tumours. A study from a single tertiary referral centre. Lung Cancer 79 289-293. (doi:10.1016/j.lungcan.2012.12.001)
36. Daddi N, Ferolla P, Urbani M, Semeraro A, Avenia N, Ribacchi R, Puma F & Daddi G 2004 Surgical treatment of neuroendocrine tumors of the lung. European Journal of Cardio-Thoracic Surgery 26 813-817. (doi:10.1016/j.ejcts. 2004.05.052) (Pubitemid 39273585)
37. Daddi N, Schiavon M, Filosso PL, Cardillo G, Ambrogi MC, De Palma A, Luzzi L, Bandiera A, Casali C, Ruffato A et al. 2013 Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids. European Journal of Cardio-Thoracic Surgery. (doi:10.1093/ejcts/ezt470)
38. Davi MV, Boninsegna L, Dalle Carbonare L, Toaiari M, Capelli P, Scarpa A, Francia G & Falconi M 2011 Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome. Neuroendocrinology 94 58-65. (doi:10.1159/000326164)
39. Davies SJ, Gosney JR, Hansell DM, Wells AU, du Bois RM, Burke MM, Sheppard MN & Nicholson AG 2007 Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 62 248-252. (doi:10.1136/thx.2006.063065) (Pubitemid 46579807)
40. Dawson MA & Kouzarides T 2012 Cancer epigenetics: from mechanism to therapy. Cell 150 12-27. (doi:10.1016/j.cell.2012.06.013)
41. Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA, Zhuang Z, Guru SC, Manickam P, Olufemi SE et al. 1997a Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Human Molecular Genetics 6 2285-2290. (doi:10.1093/hmg/6.13.2285) (Pubitemid 27501081)
42. Debelenko LV, Zhuang Z, Emmert-Buck MR, Chandrasekharappa SC, Manickam P, Guru SC, Marx SJ, Skarulis MC, Spiegel AM, Collins FS et al. 1997b Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Research 57 2238-2243. (Pubitemid 27247044)
43. Dickson PV, Rich TA, Xing Y, Cote GJ, Wang H, Perrier ND, Evans DB, Lee JE & Grubbs EG 2011 Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. Surgery 150 1143-1152. (doi:10.1016/j.surg.2011.09.028)
44. Divisi D, Di Tommaso S, Imbriglio G & Crisci R 2008 Multiple endocrine neoplasia with pulmonary localization: a new protocol of approach. Scientific World Journal 8 788-792. (doi:10.1100/tsw.2008.103)
45. Dong Q, Debelenko LV, Chandrasekharappa SC, Emmert-Buck MR, Zhuang Z, Guru SC, Manickam P, Skarulis M, Lubensky IA, Liotta LA et al. 1997 Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. Journal of Clinical Endocrinology and Metabolism 82 1416-1420. (doi:10.1210/jcem.82.5.3944) (Pubitemid 27200411)
46. Donow C, Pipeleers-Marichal M, Schroder S, Stamm B, Heitz PU & Kloppel G 1991 Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy. Cancer 68 1329-1334. (doi:10.1002/1097-0142(19910915)68:6〈1329::AID- CNCR2820680624〉3.0.CO;2-7)
47. Dreijerink KM, Mulder KW, Winkler GS, Höppener JW, Lips CJ & Timmers HT 2006 Menin links estrogen receptor activation to histone H3K4 trimethylation. Cancer Research 66 4929-4935. (doi:10.1158/0008-5472.CAN-05- 4461)
48. Dreijerink KM, Varier RA, van Beekum O, Jeninga EH, Hoppener JW, Lips CJ, Kummer JA, Kalkhoven E & Timmers HT 2009 The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor γ-dependent adipocyte differentiation. Molecular and Cellular Biology 29 5060-5069. (doi:10.1128/MCB.01001-08)
49. Dry J, Lebrigand H, Pradalier A, Leynadier F & Huguier M 1975 Familial bronchial carcinoid and polyendocrine adenomatosis. Annals de médicine interne 126 491-496.
50. Duh QY, Hybarger CP, Geist R, Gamsu G, Goodman PC, Gooding GA & Clark OH 1987 Carcinoids associated with multiple endocrine neoplasia syndromes. American Journal of Surgery 154 142-148. (doi:10.1016/0002-9610(87)90305-9) (Pubitemid 17104937)
51. Ekeblad S, Skogseid B, Dunder K, Oberg K & Eriksson B 2008 Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clinical Cancer Research 14 7798-7803. (doi:10.1158/1078-0432.CCR-08-0734)
52. Ellison EC, Sparks J, Verducci JS, Johnson JA, Muscarella P, BloomstonM & Melvin WS 2006 50-Year appraisal of gastrinoma: recommendations for staging and treatment. Journal of the American College of Surgeons 202 897-905. (doi:10.1016/j.jamcollsurg.2006.02.013) (Pubitemid 43776448)
53. Fabbri HC, Mello MP, Soardi FC, Esquiaveto-Aun AM, Oliveira DM, Denardi FC, Moura-Neto A, Garmes HM, Baptista MT, Matos PS et al. 2010 Long-term follow-up of an 8-year-old boy with insulinoma as the first manifestation of a familial form of multiple endocrine neoplasia type 1. Arquivos Brasileiros de Endocrinologia e Metabologia 54 754-760. (doi:10.1590/S0004-27302010000800016)
54. Farhangi M, Taylor J, Havey A & O'Dorisio TM 1987 Neuroendocrine (carcinoid) tumor of the lung and type I multiple endocrine neoplasia. Southern Medical Journal 80 1459-1462. (doi:10.1097/00007611-198711000-00033) (Pubitemid 18003270)
55. Fendrich V, Langer P, Celik I, Bartsch DK, Zielke A, Ramaswamy A & Rothmund M 2006 An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Annals of Surgery 244 845-851 (discussion 852-853). (doi:10.1097/01.sla.0000246951.21252.60)
56. Fendrich V, Habbe N, Celik I, Langer P, Zielke A, Bartsch DK & Rothmund M 2007 Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas-experience with 144 patients. Deutsche Medizinische Wochenschrift 132 195-200. (doi:10.1055/s-2007-959309) (Pubitemid 46395765)
57. Fero ML, RivkinM, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM et al. 1996 A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85 733-744. (doi:10.1016/S0092-8674(00)81239-8)
58. Ferolla P, Falchetti A, Filosso P, Tomassetti P, Tamburrano G, Avenia N, Daddi G, Puma F, Ribacchi R, Santeusanio F et al. 2005 Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. Journal of Clinical Endocrinology and Metabolism 90 2603-2609. (doi:10.1210/jc.2004-1155) (Pubitemid 40686297)
59. Ferolla P, Daddi N, Urbani M, Semeraro A, Ribacchi R, Giovenali P, Ascani S, De Angelis V, Crino L, Puma F et al. 2009 Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids. Journal of Thoracic Oncology 4 383-387. (doi:10.1097/JTO. 0b013e318197f2e7)
60. Fink G, KrelbaumT, Yellin A, Bendayan D, Saute M, GlazerM& KramerMR 2001 Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 119 1647-1651. (doi:10.1378/chest.119.6.1647) (Pubitemid 32744917)
61. Finkelstein SD, Hasegawa T, Colby T & Yousem SA 1999 11q13 Allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice. American Journal of Pathology 155 633-640. (doi:10.1016/S0002-9440(10)65159-0) (Pubitemid 29370413)
62. Franklin DS, Godfrey VL, LeeH, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L & Xiong Y 1998 CDK inhibitors p18INK4c and p27Kip1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes and Development 12 2899-2911. (doi:10.1101/gad.12.18.2899) (Pubitemid 28440148)
63. Franklin DS, Godfrey VL, O'Brien DA, Deng C & Xiong Y 2000 Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Molecular and Cellular Biology 20 6147-6158. (doi:10.1128/MCB.20.16.6147-6158.2000) (Pubitemid 30613062)
64. Friedman E, Sakaguchi K, Bale A, Falchetti A, Streeten E, Zimering M, Weinstein L, McBride W, Nakamura Y, Brandi M et al. 1989 Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. New England Journal of Medicine 321 1057. (doi:10.1056/NEJM198907273210402)
65. Fukai I, Masaoka A, Fujii Y, Yamakawa Y, Yokoyama T, Murase T& Eimoto T 1999 Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients. Annals of Thoracic Surgery 67 208-211. (doi:10.1016/S0003-4975(98)01063-7) (Pubitemid 29138755)
66. Gal AA, Kornstein MJ, Cohen C, Duarte IG, Miller JI & Mansour KA 2001 Neuroendocrine tumors of the thymus: a clinicopathological and prognostic study. Annals of Thoracic Surgery 72 1179-1182. (doi:10.1016/S0003-4975(01) 03032-6) (Pubitemid 32938001)
67. Garby L, Caron P, Claustrat F, Chanson P, Tabarin A, Rohmer V, Arnault G, Bonnet F, Chabre O, Christin-Maitre S et al. 2012 Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases. Journal of Clinical Endocrinology and Metabolism 97 2093-2104. (doi:10.1210/jc.2011-2930)
68. Garcia-Yuste M, Matilla JM, Cueto A, Paniagua JM, Ramos G, CanizaresMA & Muguruza I 2007 Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung. European Journal of Cardio-Thoracic Surgery 31 192-197. (doi:10.1016/j.ejcts.2006.11.031) (Pubitemid 46150082)
69. Gaur P, Leary C & Yao JC 2010 Thymic neuroendocrine tumors: a SEER database analysis of 160 patients. Annals of Surgery 251 1117-1121. (doi:10.1097/SLA.0b013e3181dd4ec4)
70. Geerdink EA, Van der Luijt RB & Lips CJ 2003 Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening? European Journal of Endocrinology 149 577-582. (doi:10.1530/eje.0.1490577) (Pubitemid 38054703)
71. Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, Mäkinen MJ, Tuppurainen K, Paschke R et al. 2007 Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. Journal of Clinical Endocrinology and Metabolism 92 3321-3325. (doi:10.1210/jc.2006-2843) (Pubitemid 47236408)
72. Gibril F, Venzon DJ, Ojeaburu JV, Bashir S & Jensen RT 2001 Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form. Journal of Clinical Endocrinology and Metabolism 86 5282-5293. (doi:10.1210/jcem.86.11.8011) (Pubitemid 33070249)
73. Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, Reynolds JC, Louie A, Entsuah LK, Huang K et al. 2003 Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. Journal of Clinical Endocrinology and Metabolism 88 1066-1081. (doi:10.1210/jc.2002- 021314) (Pubitemid 36337758)
74. Giudici F, Nesi G, Brandi ML & Tonelli F 2012 Surgical management of insulinomas in multiple endocrine neoplasia type 1. Pancreas 41 547-553. (doi:10.1097/MPA.0b013e3182374e08)
75. Gobl AE, Berg M, Lopez-Egido JR, Oberg K, Skogseid B & Westin G 1999 Menin represses JunD-activated transcription by a histone deacetylasedependent mechanism. Biochimica et Biophysica Acta 1447 51-56. (doi:10.1016/S0167-4781(99) 00132-3) (Pubitemid 29433856)
76. Goretzki P, Starke A, Lammers B, Schwarz K & Roher HD 2010 Pancreatic hyperinsulinism-changes of the clinical picture and importance of differences in sporadic disease course (experience with 144 patients operated in the period 1986-2009). Zentralblatt für Chirurgie 135 218-225. (doi:10.1055/s-0030- 1247316)
77. Gortz B, Roth J,Krahenmann A, de Krijger RR, Muletta-Feurer S, Rutimann K, Saremaslani P, Speel EJ, Heitz PU & Komminoth P 1999 Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. American Journal of Pathology 154 429-436. (doi:10.1016/S0002- 9440(10)65289-3) (Pubitemid 29094093)
78. Goudet P, Murat A, Cardot-Bauters C, Emy P, Baudin E, du Boullay Choplin H, Chapuis Y, Kraimps JL, Sadoul JL, Tabarin A et al. 2009 Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines). World Journal of Surgery 33 1197-1207. (doi:10.1007/s00268-009-9980-y)
79. Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, Niccoli P, Menegaux F, Chabrier G, Borson-Chazot F et al. 2010 Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients. World Journal of Surgery 34 249-255. (doi:10.1007/s00268-009-0290-1)
80. Goudet P, Bonithon-KoppC, Murat A, Ruszniewski P,Niccoli P, Menegaux F, Chabrier G, Borson-Chazot F, Tabarin A, Bouchard P et al. 2011 Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines. European Journal of Endocrinology 165 97-105. (doi:10.1530/EJE-10-0950)
81. Gracanin A, Dreijerink KM, van der Luijt RB, Lips CJ & Hoppener JW 2009 Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis. Cancer Research 69 6371-6374. (doi:10.1158/0008-5472.CAN-09-0678)
82. Grama D, Skogseid B,Wilander E, Eriksson B, Martensson H, Cedermark B, Ahren B, Kristofferson A, Oberg K, Rastad J et al. 1992 Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment. World Journal of Surgery 16 611-618 (discussion 618-619). (doi:10.1007/BF02067335)
83. Guenther M, Levine S, Boyer L, Jaenisch R & Young R 2007 A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130 77-88. (doi:10.1016/j.cell.2007.05.042)
84. Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS & Chandrasekharappa SC 1998 Menin, the product of the MEN1 gene, is a nuclear protein. PNAS 95 1630-1634. (doi:10.1073/pnas.95.4.1630) (Pubitemid 28103444)
85. Gurung B, Feng Z & Hua X 2013a Menin directly represses expression of Gli1 independent of the canonical Hedgehog signaling pathway. Molecular Cancer Research 11 1215-1222. (doi:10.1158/1541-7786.MCR-13-0170)
86. Gurung B, Feng Z, Iwamoto DV, Thiel A, Jin G, Fan CM, Ng JM, Curran T & Hua X 2013b Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome. Cancer Research 73 2650-2658. (doi:10.1158/0008-5472.CAN-12- 3158)
87. Hamaji M, Allen MS, Cassivi SD, Nichols FC III, Wigle DA, Deschamps C & Shen KR 2012 The role of surgical management in recurrent thymic tumors. Annals of Thoracic Surgery 94 247-254 (discussion 254). (doi:10.1016/j. athoracsur.2012.02.092)
88. Heppner C, Bilimoria KY, Agarwal SK, Kester M, Whitty LJ, Guru SC, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ et al. 2001 The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation. Oncogene 20 4917-4925. (doi:10.1038/sj.onc.1204529) (Pubitemid 32769781)
89. Hessman O, Lindberg D, Skogseid B, Carling T, Hellman P, Rastad J, Akerström G & Westin G 1998 Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas. Cancer Research 58 377-379. (Pubitemid 28087391)
90. Hessman O, Lindberg D, Einarsson A, Lillhager P, Carling T, Grimelius L, Eriksson B, Akerstrom G, Westin G & Skogseid B 1999 Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors. Genes, Chromosomes & Cancer 26 258-264. (doi:10.1002/(SICI)1098- 2264(199911)26:3〈258::AIDGCC11〉3.0.CO;2-2) (Pubitemid 29468347)
91. Hessman O, Skogseid B, Westin G & Akerstrom G 2001 Multiple allelic deletions and intratumoral genetic heterogeneity in MEN1 pancreatic tumors. Journal of Clinical Endocrinology and Metabolism 86 1355-1361. (doi:10.1210/jcem.86.3.7332) (Pubitemid 32323028)
92. Huang J, Gurung B, Wan B, Matkar S, Veniaminova NA, Wan K, Merchant JL, Hua X & Lei M 2012 The same pocket in menin binds both MLL and JUND but has opposite effects on transcription. Nature 482 542-546. (doi:10.1038/nature10806)
93. Hughes C, Rozenblatt-Rosen O, Milne T, Copeland T, Levine S, Lee J, Hayes D, Shanmugam K, Bhattacharjee A, Biondi C et al. 2004 Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Molecular Cell 13 587-597. (doi:10.1016/S1097-2765(04)00081-4) (Pubitemid 38299385)
94. Ikeo Y, Sakurai A, Suzuki R, Zhang MX, Koizumi S, Takeuchi Y, Yumita W, Nakayama J & Hashizume K 2000 Proliferation-associated expression of the MEN1 gene as revealed by in situ hybridization: possible role of the menin as a negative regulator of cell proliferation under DNA damage. Laboratory Investigation 80 797-804. (doi:10.1038/labinvest.3780084) (Pubitemid 30421797)
95. Imamura M, Komoto I, Ota S, Hiratsuka T, Kosugi S, Doi R, Awane M & Inoue N 2011 Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients. World Journal of Gastroenterology 17 1343-1353. (doi:10.3748/wjg.v17.i10.1343)
96. Ito T, Igarashi H, Uehara H, Berna MJ & Jensen RT 2013 Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Medicine 92 135-181. (doi:10.1097/MD.0b013e3182954af1)
97. Jensen RT 1998 Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. Journal of Internal Medicine 243 477-488. (doi:10.1046/j.1365-2796.1998.00281.x) (Pubitemid 28312244)
98. Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, Schulick RD, Tang LH, Wolfgang CL, Choti MA et al. 2011 DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331 1199-1203. (doi:10.1126/science.1200609)
99. Jin S,Mao H, Schnepp RW, Sykes SM, Silva AC, D'Andrea AD & Hua X 2003 Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Research 63 4204-4210. (Pubitemid 36917947)
100. Kaji H, Canaff L, Lebrun JJ, Goltzman D & Hendy GN 2001 Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type b signaling. PNAS 98 3837-3842. (doi:10.1073/pnas.061358098) (Pubitemid 32249858)
101. Kann PH, Balakina E, Ivan D, Bartsch DK, Meyer S, Klose KJ, Behr T & Langer P 2006 Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study. Endocrine-Related Cancer 13 1195-1202. (doi:10.1677/erc.1.01220) (Pubitemid 46212573)
102. Karges W, Schaaf L, Dralle H & Boehm BO 2000 Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1). Experimental and Clinical Endocrinology & Diabetes 108 334-340. (doi:10.1055/s-2000-8146) (Pubitemid 30621260)
103. Karnik SK, Hughes CM, Gu X, Rozenblatt-Rosen O, McLean GW, Xiong Y, Meyerson M & Kim SK 2005 Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. PNAS 102 14659-14664. (doi:10.1073/pnas.0503484102) (Pubitemid 41457112)
104. Karnik SK, Chen H, McLean GW, Heit JJ, Gu X, Zhang AY, Fontaine M, Yen MH & Kim SK 2007 Menin controls growth of pancreatic β-cells in pregnant mice and promotes gestational diabetes mellitus. Science 318 806-809. (doi:10.1126/science.1146812) (Pubitemid 351411773)
105. Kim H, Lee J, Cho E, Liu J & Youn H 2003 Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Research 63 6135-6139. (Pubitemid 37255151)
106. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday A, Frohman L & Koff A 1996 Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85 721-732. (doi:10.1016/S0092-8674(00)81238-6)
107. Kloppel G, Willemer S, Stamm B, Hacki WH & Heitz PU 1986 Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients. Cancer 57 1824-1832. (doi:10.1002/1097-0142(19860501) 57:9〈1824::AID- CNCR2820570920〉3.0.CO;2-Q)
108. Knudson A 1971 Mutation and cancer: statistical study of retinoblastoma. PNAS 68 820-823. (doi:10.1073/pnas.68.4.820)
109. Kondo K & Monden Y 2003 Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Annals of Thoracic Surgery 76 878-884 (discussion 884-885). (doi:10.1016/S0003-4975(03)00555-1)
110. Kouvaraki MA, Lee JE, Shapiro SE, Gagel RF, Sherman SI, Sellin RV, Cote GJ & Evans DB 2002 Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Archives of Surgery 137 641-647. (doi:10.1001/archsurg.137.6. 641) (Pubitemid 34603007)
111. Kouvaraki MA, Shapiro SE, Cote GJ, Lee JE, Yao JC, Waguespack SG, Gagel RF, Evans DB & Perrier ND 2006 Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World Journal of Surgery 30 643-653. (doi:10.1007/s00268-006-0360-y) (Pubitemid 43724089)
112. Kouzarides T 2007 Chromatin modifications and their function. Cell 128 693-705. (doi:10.1016/j.cell.2007.02.005) (Pubitemid 46273577)
113. Krivtsov A & Armstrong S 2007 MLL translocations, histone modifications and leukaemia stem-cell development. Nature Reviews. Cancer 7 823-833. (doi:10.1038/nrc2253) (Pubitemid 350006257)
114. de Laat JM, Tham E, Pieterman CR, Vriens MR, Dorresteijn JA, Bots ML, Nordenskjold M, van der Luijt RB & Valk GD 2012 Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors. European Journal of Endocrinology 167 181-187. (doi:10.1530/EJE-12-0210)
115. Lairmore TC, Chen VY, DeBenedetti MK, Gillanders WE, Norton JA & Doherty GM 2000 Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Annals of Surgery 231 909-918. (doi:10.1097/00000658- 200006000-00016) (Pubitemid 30350250)
116. Larsson C, Skogseid B, Oberg K, Nakamura Y & Nordenskjöld M 1988 Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332 85-87. (doi:10.1038/332085a0) (Pubitemid 18083554)
117. Le Bodic MF, Heymann MF, Lecomte M, Berger N, Berger F, Louvel A, De Micco C, Patey M, De Mascarel A, Burtin F et al. 1996 Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia, type I. American Journal of Surgical Pathology 20 1378-1384. (doi:10.1097/00000478- 199611000-00009) (Pubitemid 26367209)
118. Lejonklou MH, Barbu A, Stalberg P & Skogseid B 2012 Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor. Endocrinology 153 2588-2598. (doi:10.1210/en.2011-1924)
119. Lemmens I, Van de VenW, Kas K, Zhang C, Giraud S,Wautot V, Buisson N, De Witte K, Salandre J, Lenoir G et al. 1997 Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Human Molecular Genetics 6 1177-1183. (doi:10.1093/hmg/6.7.1177) (Pubitemid 27308405)
120. Lemos MC & Thakker RV 2008 Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Human Mutation 29 22-32. (doi:10.1002/humu.20605)
121. Levy-Bohbot N, Merle C, Goudet P, Delemer B, Calender A, Jolly D, Thiefin G & Cadiot G 2004 Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry. Gastroenterologie Clinique et Biologique 28 1075-1081. (doi:10.1016/S0399-8320(04)95184-6) (Pubitemid 39655853)
122. Lin W, Cao J, Liu J, Beshiri ML, Fujiwara Y, Francis J, Cherniack AD, Geisen C, Blair LP, Zou MR et al. 2011 Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1. PNAS 108 13379-13386. (doi:10.1073/pnas.1110104108)
123. Lindberg D, Akerstrom G & Westin G 2008 Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours. Clinical Endocrinology 68 271-277. (doi:10.1111/j.1365-2265.2007.03034.x)
124. Lopez CL, Waldmann J, Fendrich V, Langer P, Kann PH & Bartsch DK 2011 Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1. Langenbeck's Archives of Surgery 396 1187-1196. (doi:10.1007/s00423-011-0828-1)
125. Lopez CL, Falconi M, Waldmann J, Boninsegna L, Fendrich V, Goretzki PK, Langer P, Kann PH, Partelli S & Bartsch DK 2013 Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1. Annals of Surgery 257 308-314. (doi:10.1097/SLA.0b013e3182536339)
126. Lourenco-Jr DM, Toledo RA, Coutinho FL, Margarido LC, Siqueira SA, dos Santos MA, Montenegro FL, Machado MC & Toledo SP 2007 The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1. Clinics 62 465-476. (doi:10.1590/S1807-59322007000400014)
127. Lowney JK, Frisella MM, Lairmore TC & Doherty GM 1998 Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size. Surgery 124 1043-1048 (discussion 1048-1049). (doi:10.1067/msy.1998.92561)
128. Lu J, Herrera PL, Carreira C, Bonnavion R, Seigne C, Calender A, Bertolino P & Zhang CX 2010 Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development. Gastroenterology 138 1954-1965. (doi:10.1053/j.gastro.2010.01.046)
129. Lubensky I, Debelenko L, Zhuang Z, Emmert-Buck M, Dong Q, Chandrasekharappa S, Guru S, Manickam P, Olufemi S, Marx S et al. 1996 Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Research 56 5272-5278. (Pubitemid 26383047)
130. Luzi E & Brandi ML 2011 AremicroRNAs involved in the endocrine-specific pattern of tumorigenesis in multiple endocrine neoplasia type 1? Endocrine Practice 17 (Suppl 3) 58-63. (doi:10.4158/EP11062.RA)
131. Luzi E, Marini F, Giusti F, Galli G, Cavalli L & Brandi ML 2012 The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the "Knudson's second hit". PLoS ONE 7 e39767. (doi:10.1371/journal.pone.0039767)
132. MalumbresM& Barbacid M 2001 To cycle or not to cycle: a critical decision in cancer. Nature Reviews. Cancer 1 222-231. (doi:10.1038/35106065) (Pubitemid 33741897)
133. Manley NR & Capecchi MR 1998 Hox group 3 paralogs regulate the development and migration of the thymus, thyroid, and parathyroid glands. Developmental Biology 195 1-15. (doi:10.1006/dbio.1997.8827) (Pubitemid 28146373)
134. Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS & Liotta LA 1998 Multiple endocrine neoplasia type 1: clinical and genetic topics. Annals of Internal Medicine 129 484-494. (doi:10.7326/0003-4819-129-6-199809150-00011) (Pubitemid 28428085)
135. Matkar S, Thiel A & Hua X 2013 Menin: a scaffold protein that controls gene expression and cell signaling. Trends in Biochemical Sciences 38 394-402. (doi:10.1016/j.tibs.2013.05.005)
136. Matsuda KM, Nobrega R, Quezado M, Schrump DS & Filie AC 2010 Melanocytic bronchopulmonary carcinoid tumor in a patient with multiple endocrine neoplasia syndrome type 1: a case report with emphasis on intraoperative cytological findings. Diagnostic Cytopathology 38 669-674. (doi:10.1002/dc.21296)
137. McMillan R & Matsui W 2012 Molecular pathways: the Hedgehog signaling pathway in cancer. Clinical Cancer Research 18 4883-4888. (doi:10.1158/1078- 0432.CCR-11-2509)
138. Melvin WS, Johnson JA, Sparks J, Innes JT & Ellison EC 1993 Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia. Surgery 114 1183-1188. (Pubitemid 24004743)
139. Mensah-Osman EJ, Veniaminova NA &Merchant JL 2011 Menin and JunD regulate gastrin gene expression through proximal DNA elements. American Journal of Physiology. Gastrointestinal and Liver Physiology 301 G783-G790. (doi:10.1152/ajpgi.00160.2011)
140. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D et al. 2005 Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. PNAS 102 749-754. (doi:10.1073/pnas.0408836102)
141. Montero C, Sanjuan P, Fernandez Mdel M, Vidal I, Verea H & Cordido F 2010 Bronchial carcinoid and type 1 multiple endocrine neoplasia syndrome. A case report. Archivos de Bronconeumología 46 559-561. (doi:10.1016/S1579-2129(11)60009-8)
142. de Montpreville VT, Macchiarini P & Dulmet E 1996 Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases. Journal of Thoracic and Cardiovascular Surgery 111 134-141. (doi:10.1016/S0022-5223(96)70409-9) (Pubitemid 26035180)
143. Moran CA & Suster S 2000a Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. American Journal of Clinical Pathology 114 100-110. (doi:10.1309/3PDN-PMT5-EQTM-H0CD) (Pubitemid 34453191)
144. Moran CA & Suster S 2000b Thymic neuroendocrine carcinomas with combined features ranging from well-differentiated (carcinoid) to small cell carcinoma, A clinicopathologic and immunohistochemical study of 11 cases. American Journal of Clinical Pathology 113 345-350. (doi:10.1309/Q01U-60BL-VEV4- TWR1) (Pubitemid 30217380)
145. Murai MJ, Chruszcz M, Reddy G, Grembecka J & Cierpicki T 2011 Crystal structure of menin reveals binding site for mixed lineage leukemia (MLL) protein. Journal of Biological Chemistry 286 31742-31748. (doi:10.1074/jbc.M111. 258186)
146. Murat A, Heymann MF, Bernat S, Dupas B, Delajartre AY, Calender A, Despins P, Michaud JL, Giraud S, Le Bodic MF et al. 1997 Thymic and bronchial neuroendocrine tumors in multiple endocrine neoplasia type 1. GENEM1. Presse Médicale 26 1616-1621. (Pubitemid 27501931)
147. Naalsund A, Rostad H, Strom EH, Lund MB & Strand TE 2011 Carcinoid lung tumors-incidence, treatment and outcomes: a population-based study. European Journal of Cardio-Thoracic Surgery 39 565-569. (doi:10.1016/j.ejcts. 2010.08.036)
148. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I & Loh DY 1996 Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85 707-720. (doi:10.1016/S0092-8674(00)81237-4)
149. Nikfarjam M, Warshaw AL, Axelrod L, Deshpande V, Thayer SP, Ferrone CR & Fernandez-del Castillo C 2008 Improved contemporary surgical management of insulinomas: a 25-year experience at theMassachusetts General Hospital. Annals of Surgery 247 165-172. (doi:10.1097/SLA.0b013e31815792ed)
150. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, Goebel SU, Peghini PL, Roy PK, Gibril F et al. 1999 Surgery to cure the Zollinger-Ellison syndrome. New England Journal of Medicine 341 635-644. (doi:10.1056/NEJM199908263410902) (Pubitemid 29399042)
151. Norton JA, Alexander HR, Fraker DL, Venzon DJ, Gibril F & Jensen RT 2001 Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Annals of Surgery 234 495-505 (discussion 505-506). (doi:10.1097/00000658- 200110000-00009)
152. van Nuland R, Smits AH, Pallaki P, Jansen PWTC, VermeulenM& Timmers HTM 2013 Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes. Molecular and Cellular Biology 33 2067-2077. (doi:10.1128/MCB.01742-12)
153. Occhi G, Regazzo D, Trivellin G, Boaretto F, Ciato D, Bobisse S, Ferasin S, Cetani F, Pardi E, Korbonits M et al. 2013 A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype. PLoS Genetics 9 e1003350. (doi:10.1371/journal.pgen.1003350)
154. Okoye CC, Jablons DM, Jahan TM, Kukreja J, Cardozo S & Yom SS 2013 Divergent management strategies for typical versus atypical carcinoid tumors of the thoracic cavity. American Journal of Clinical Oncology. (doi:10.1097/COC. 0b013e31827a7f6d)
155. Pannett AA & Thakker RV 2001 Somatic mutations in MEN type 1 tumors, consistent with the Knudson "two-hit" hypothesis. Journal of Clinical Endocrinology and Metabolism 86 4371-4374. (doi:10.1210/jcem.86.9.7844)
156. Pellegata N, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Höfler H, Fend F, Graw J & Atkinson M 2006 Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. PNAS 103 15558-15563. (doi:10.1073/pnas.0603877103) (Pubitemid 44625631)
157. Perren A, Anlauf M, Henopp T, Rudolph T, Schmitt A, Raffel A, Gimm O, Weihe E, Knoefel WT, Dralle H et al. 2007 Multiple endocrine neoplasia type 1 (MEN1): loss of one MEN1 allele in tumors and monohormonal endocrine cell clusters but not in islet hyperplasia of the pancreas. Journal of Clinical Endocrinology and Metabolism 92 1118-1128. (doi:10.1210/jc.2006-1944) (Pubitemid 46465691)
158. Petzmann S, Ullmann R, Klemen H, Renner H & Popper HH 2001 Loss of heterozygosity on chromosome arm 11q in lung carcinoids. Human Pathology 32 333-338. (doi:10.1053/hupa.2001.22762) (Pubitemid 32246809)
159. Pieterman CR, Schreinemakers JM, Koppeschaar HP, Vriens MR, Rinkes IH, Zonnenberg BA, van der Luijt RB & Valk GD 2009 Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome. Clinical Endocrinology 70 575-581. (doi:10.1111/j.1365-2265.2008.03324. x)
160. Pipeleers-Marichal M, Somers G, Willems G, Foulis A, Imrie C, Bishop AE, Polak JM, Hacki WH, Stamm B, Heitz PU et al. 1990 Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. New England Journal of Medicine 322 723-727. (doi:10.1056/ NEJM199003153221103) (Pubitemid 20092807)
161. Pipeleers-Marichal M, Donow C, Heitz PU & Kloppel G 1993 Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I. World Journal of Surgery 17 481-488. (doi:10.1007/BF01655107) (Pubitemid 23228401)
162. Proye C, Stalnikiewicz G, Wemeau JL, Porchet N, D'Herbomez M, Maunoury V & Bauters C 2004 Genetically-driven or supposed geneticrelated insulinomas in adults: validation of the surgical strategy proposed by the A.F.C.E./G.E.N.E.M. Annales d'Endocrinologie 65 149-161. (doi:10.1016/S0003- 4266(04)95663-6) (Pubitemid 38812354)
163. Pusceddu S, Catena L, Valente M, Buzzoni R, Formisano B, Del Vecchio M, Ducceschi M, Tavecchio L, Fabbri A & Bajetta E 2010 Long-term follow up of patients affected by pulmonary carcinoid at the Istituto Nazionale Tumori of Milan: a retrospective analysis. Journal of Thoracic Disease 2 16-20.
164. Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P et al. 2006 TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Archiv 449 395-401. (doi:10.1007/s00428-006-0250-1) (Pubitemid 44451313)
165. Rindi G, Falconi M, Klersy C, Albarello L, Boninsegna L, Buchler MW, Capella C, Caplin M, Couvelard A, Doglioni C et al. 2012 TNM staging of neoplasms of the endocrine pancreas: results from a large International Cohort Study. Journal of the National Cancer Institute 104 764-777. (doi:10.1093/jnci/djs208)
166. Rosai J & Higa E 1972 Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. Clinicopathologic study of 8 cases. Cancer 29 1061-1074. (doi:10.1002/1097-0142(197204)29:4〈1061::AID- CNCR2820290456〉3.0.CO;2-3)
167. Rosai J, Higa E & Davie J 1972 Mediastinal endocrine neoplasm in patients with multiple endocrine adenomatosis. A previously unrecognized association. Cancer 29 1075-1083. (doi:10.1002/1097-0142(197204) 29:4〈1075::AID-CNCR2820290457〉3.0.CO;2-O)
168. Ruszniewski P, Podevin P, Cadiot G, Marmuse JP, Mignon M, Vissuzaine C, Bonfils S & Lehy T 1993 Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. Pancreas 8 295-304. (doi:10.1097/00006676-199305000-00003) (Pubitemid 23119100)
169. Ruthenburg AJ, Allis CD & Wysocka J 2007 Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Molecular Cell 25 15-30. (doi:10.1016/j.molcel.2006.12.014) (Pubitemid 46049068)
170. Sachithanandan N, Harle RA & Burgess JR 2005 Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1. Cancer 103 509-515. (doi:10.1002/cncr.20825)
171. Sakurai A, Katai M, Yamashita K, Mori J, Fukushima Y & Hashizume K 2007 Long-term follow-up of patients with multiple endocrine neoplasia type 1. Endocrine Journal 54 295-302. (doi:10.1507/endocrj.K06-147) (Pubitemid 46798652)
172. Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D et al. 2012a Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clinical Endocrinology 76 533-539. (doi:10.1111/j.1365-2265.2011.04227.x)
173. Sakurai A, Yamazaki M, Suzuki S, Fukushima T, Imai T, Kikumori T, Okamoto T, Horiuchi K, Uchino S, Kosugi S et al. 2012b Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the database of the MEN Consortium of Japan. Endocrine Journal 59 859-866. (doi:10.1507/endocrj.EJ12-0173)
174. Sakurai A, Imai T, Kikumori T, Horiuchi K, Okamoto T, Uchino S, Kosugi S, Suzuki S, Suyama K, Yamazaki M et al. 2013 Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions. Clinical Endocrinology 78 248-254. (doi:10.1111/j.1365-2265.2012.04467.x)
175. Santos-Rosa H, Schneider R, Bannister A, Sherriff J, Bernstein B, Emre N, Schreiber S, Mellor J & Kouzarides T 2002 Active genes are tri-methylated at K4 of histone H3. Nature 419 407-411. (doi:10.1038/nature01080)
176. Scacheri PC, Crabtree JS, Kennedy AL, Swain GP, Ward JM, Marx SJ, Spiegel AM & Collins FS 2004 Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1. Mammalian Genome 15 872-877. (doi:10.1007/s00335- 004-2395-z) (Pubitemid 40064198)
177. Scacheri PC, Davis S, Odom DT, Crawford GE, Perkins S, Halawi MJ, Agarwal SK, Marx SJ, Spiegel AM, Meltzer PS et al. 2006 Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genetics 2 e51. (doi:10.1371/journal.pgen.0020051)
178. Scarpa A, Mantovani W, Capelli P, Beghelli S, Boninsegna L, Bettini R, Panzuto F, Pederzoli P, delle Fave G & Falconi M 2010 Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Modern Pathology 23 824-833. (doi:10.1038/modpathol.2010.58)
179. Schaaf L, Pickel J, Zinner K, Hering U, Hofler M, Goretzki PE, Spelsberg F, Raue F, von zur Muhlen A, Gerl H et al. 2007 Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1. Experimental and Clinical Endocrinology & Diabetes 115 509-517. (doi:10.1055/s-2007-970160) (Pubitemid 350056763)
180. Service FJ, McMahon MM, O'Brien PC & Ballard DJ 1991 Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clinic Proceedings 66 711-719. (doi:10.1016/S0025-6196(12)62083-7)
181. Shen HC, Rosen JE, Yang LM, Savage SA, Burns AL, Mateo CM, Agarwal SK, Chandrasekharappa SC, Spiegel AM, Collins FS et al. 2008 Parathyroid tumor development involves deregulation of homeobox genes. Endocrine-Related Cancer 15 267-275. (doi:10.1677/ERC-07-0191) (Pubitemid 351449745)
182. Shepherd JJ 1991 The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized? Archives of Surgery 126 935-952. (doi:10.1001/archsurg.1991.01410320017001)
183. Shi K, Parekh VI, Roy S, Desai SS & Agarwal SK 2013 The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators. Endocrine-Related Cancer 20 111-122. (doi:10.1530/ERC-12-0077)
184. Sierra J, Yoshida T, Joazeiro C & Jones K 2006 The APC tumor suppressor counteracts β-catenin activation and H3K4 methylation at Wnt target genes. Genes and Development 20 586-600. (doi:10.1101/gad.1385806)
185. Simonds WF, Varghese S, Marx SJ & Nieman LK 2012 Cushing's syndrome in multiple endocrine neoplasia type 1. Clinical Endocrinology 76 379-386. (doi:10.1111/j.1365-2265.2011.04220.x)
186. Singh MH, Fraker DL & Metz DC 2012 Importance of surveillance for multiple endocrine neoplasia-1 and surgery in patients with sporadic Zollinger-Ellison syndrome. Clinical Gastroenterology and Hepatology 10 1262-1269. (doi:10.1016/j.cgh.2012.08.014)
187. Skogseid B, Oberg K, Akerstrom G, Eriksson B, Westlin JE, Janson ET, Eklof H, Elvin A, Juhlin C & Rastad J 1998 Limited tumor involvement found at multiple endocrine neoplasia type I pancreatic exploration: can it be predicted by preoperative tumor localization? World Journal of Surgery 22 673-677 (discussion 677-678). (doi:10.1007/s002689900451)
188. Snabboon T, Plengpanich W, Siriwong S,Wisedopas N, Suwanwalaikorn S, Khovidhunkit W & Shotelersuk V 2005 A novel germline mutation, 1793delG, of the MEN1 gene underlying multiple endocrine neoplasia type 1. Japanese Journal of Clinical Oncology 35 280-282. (doi:10.1093/jjco/hyi080)
189. Soga J, Yakuwa Y & Osaka M 1999 Evaluation of 342 cases of mediastinal/thymic carcinoids collected from literature: a comparative study between typical carcinoids and atypical varieties. Annals of Thoracic and Cardiovascular Surgery 5 285-292.
190. Stabile BE & Passaro E Jr 1985 Benign and malignant gastrinoma. American Journal of Surgery 149 144-150. (doi:10.1016/S0002-9610(85)80024-6) (Pubitemid 15156170)
191. Stewart C, Parente F, Piehl F, Farnebo F, Quincey D, Silins G, Bergman L, Carle GF, Lemmens I, Grimmond S et al. 1998 Characterization of the mouse Men1 gene and its expression during development. Oncogene 17 2485-2493. (doi:10.1038/sj.onc.1202164) (Pubitemid 28544718)
192. Sukhodolets K, Hickman A, Agarwal S, Sukhodolets M, Obungu V, Novotny E, Crabtree J, Chandrasekharappa S, Collins F, Spiegel A et al. 2003 The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene. Molecular and Cellular Biology 23 493-509. (doi:10.1128/MCB.23.2.493-509.2003) (Pubitemid 36050544)
193. Sutliff VE, Doppman JL, Gibril F, Venzon DJ, Yu F, Serrano J & Jensen RT 1997 Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns. Journal of Clinical Oncology 15 2420-2431. (Pubitemid 27251146)
194. Swarts DR, Henfling ME, Ramaekers FC, Van Suylen RJ, Dingemans AM, Volante M, Perren A, Van Velthuysen ML, Van Engeland M & Speel EJ 2011 Reduced MEN1 gene expression in pulmonary carcinoids is associated with metastatic disease. Neuroendocrinology 94 12. (doi:10.1159/000328226)
195. Swarts DR, Ramaekers FC & Speel EJ 2012 Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Biochimica et Biophysica Acta 1826 255-271. (doi:10.1016/j.bbcan.2012. 05.001)
196. Teh BT, Hayward NK, Walters MK, Shepherd JJ, Wilkinson S, Nordenskjold M & Larsson C 1994 Genetic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Journal of Medical Genetics 31 261-262. (doi:10.1136/jmg.31.3. 261) (Pubitemid 24102218)
197. Teh BT, McArdle J, Chan SP, Menon J, Hartley L, Pullan P, Ho J, Khir A, Wilkinson S, Larsson C et al. 1997 Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine 76 21-29. (doi:10.1097/00005792-199701000-00002) (Pubitemid 27074739)
198. Teh BT, Zedenius J, Kytola S, Skogseid B, Trotter J, Choplin H, Twigg S, Farnebo F, Giraud S, Cameron D et al. 1998 Thymic carcinoids in multiple endocrine neoplasia type 1. Annals of Surgery 228 99-105. (doi:10.1097/00000658- 199807000-00015) (Pubitemid 30190322)
199. Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F & Brandi ML 2012 Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). Journal of Clinical Endocrinology and Metabolism 97 2990-3011. (doi:10.1210/jc.2012-1230)
200. Thomas-Marques L, Murat A, Delemer B, Penfornis A, Cardot-Bauters C, Baudin E, Niccoli-Sire P, Levoir D, Choplin Hdu B, Chabre O et al. 2006 Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. American Journal of Gastroenterology 101 266-273. (doi:10.1111/j.1572-0241.2006.00367.x) (Pubitemid 43381666)
201. Thompson NW 1995 The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. Journal of Internal Medicine 238 269-280. (doi:10.1111/j.1365-2796. 1995.tb00934.x)
202. Thompson NW 1998 Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. Journal of Internal Medicine 243 495-500. (doi:10.1046/j.1365-2796.1998.00307.x) (Pubitemid 28312246)
203. Thompson NW, Lloyd RV, Nishiyama RH, Vinik AI, Strodel WE, Allo MD, Eckhauser FE, Talpos G & Mervak T 1984 MEN I pancreas: a histological and immunohistochemical study. World Journal of Surgery 8 561-574. (doi:10.1007/BF01654938)
204. Tomassetti P, Campana D, Piscitelli L, Casadei R, Santini D, Nori F, Morselli-Labate AM, Pezzilli R & Corinaldesi R 2005 Endocrine pancreatic tumors: factors correlated with survival. Annals of Oncology 16 1806-1810. (doi:10.1093/annonc/mdi358) (Pubitemid 41631244)
205. Tonelli F, Fratini G, Nesi G, Tommasi MS, Batignani G, Falchetti A & Brandi ML 2006 Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Annals of Surgery 244 61-70. (doi:10.1097/01.sla.0000218073.77254.62) (Pubitemid 44297449)
206. Travis WD, Brambilla E, Muller-Hermelink HK & Harris CC (Eds) 2004 World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press.
207. Triponez F, Dosseh D, Goudet P, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Chayvialle JA, Calender A et al. 2006a Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Annals of Surgery 243 265-272. (doi:10.1097/01.sla.0000197715.96762.68) (Pubitemid 43185447)
208. Triponez F, Goudet P, Dosseh D, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Calender A & Proye CA 2006b Is surgery beneficial for MEN1 patients with small (< or=2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE World Journal of Surgery 30 654-662 (discussion 663-664). (doi:10.1007/s00268-005-0354-9)
209. Underdahl LO, Woolner LB & Black BM 1953 Multiple endocrine adenomas; report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved. Journal of Clinical Endocrinology and Metabolism 13 20-47. (doi:10.1210/jcem-13-1-20)
210. Vageli D, Daniil Z, Dahabreh J, Karagianni E, Liloglou T, Koukoulis G & Gourgoulianis K 2006 Microsatellite instability and loss of heterozygosity at the MEN1 locus in lung carcinoid tumors: a novel approach using real-time PCR with melting curve analysis in histopathologic material. Oncology Reports 15 557-564.
211. Van Box Som P, Peix JL, Cougard P, Proye C, Henry JF, Sarfati E, Visset J, Parneix M, Lecomte P, Chapuis Y et al. 1995 Pancreatic insulinomas in multiple endocrine neoplasia type I. Revue Francaise d'Endocrinologie Clinique-Nutrition et Metabolisme 36 105-117.
212. Veschi S, Lattanzio R, Aceto GM, Curia MC, Magnasco S, Angelucci D, Cama A, Piantelli M & Battista P 2012 Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids. International Journal of Oncology 41 1221-1228.
213. Vierimaa O, Ebeling TM, Kytola S, Bloigu R, Eloranta E, Salmi J, Korpi-Hyovalti E, Niskanen L, Orvola A, Elovaara E et al. 2007 Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation. European Journal of Endocrinology 157 285-294. (doi:10.1530/EJE-07-0195) (Pubitemid 47603532)
214. Vortmeyer AO, Huang S, Lubensky I & Zhuang Z 2004 Non-islet origin of pancreatic islet cell tumors. Journal of Clinical Endocrinology and Metabolism 89 1934-1938. (doi:10.1210/jc.2003-031575) (Pubitemid 38507955)
215. Walch AK, Zitzelsberger HF, Aubele MM, Mattis AE, Bauchinger M, Candidus S, Prauer HW, Werner M & Hofler H 1998 Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. American Journal of Pathology 153 1089-1098. (doi:10.1016/S0002-9440(10)65653-2) (Pubitemid 28465832)
216. Waldmann J, Fendrich V, Habbe N, Bartsch DK, Slater EP, Kann PH, Rothmund M & Langer P 2009 Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value. World Journal of Surgery 33 1208-1218. (doi:10.1007/s00268-009-9983-8)
217. Warren WH & Hammar SP 2006 The dispersed neuroendocrine system, its bronchopulmonary elements, and neuroendocrine tumors presumed to be derived from them: myths, mistaken notions, and misunderstandings. Seminars in Thoracic and Cardiovascular Surgery 18 178-182. (doi:10.1053/j.semtcvs.2006.08.003) (Pubitemid 44914570)
218. Wautot V, Khodaei S, Frappart L, Buisson N, Baro E, Lenoir GM, Calender A, Zhang CX & Weber G 2000 Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues. International Journal of Cancer 85 877-881. (doi:10.1002/(SICI)1097- 0215(20000315)85:6〈877::AID-IJC23〉.0.CO;2-F) (Pubitemid 30131481)
219. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Strader DB, Gibril F, Metz DC, Fraker DL, Norton JA et al. 1995 Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 108 1637-1649. (doi:10.1016/0016-5085(95)90124-8)
220. Wilkinson S, Teh BT, Davey KR, McArdle JP, Young M & Shepherd JJ 1993 Cause of death in multiple endocrine neoplasia type 1. Archives of Surgery 128 683-690. (doi:10.1001/archsurg.1993.01420180085016) (Pubitemid 23167738)
221. Williams ED & Celestin LR 1962 The association of bronchial carcinoid and pluriglandular adenomatosis. Thorax 17 120-127. (doi:10.1136/thx.17.2.120)
222. Wilson SD, Krzywda EA, Zhu YR, Yen TW, Wang TS, Sugg SL & Pappas SG 2008 The influence of surgery in MEN-1 syndrome: observations over 150 years. Surgery 144 695-701 (discussion 701-702). (doi:10.1016/j.surg.2008.06.015)
223. Yaguchi H, Ohkura N, Takahashi M, Nagamura Y, Kitabayashi I & Tsukada T 2004 Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway. Molecular and Cellular Biology 24 6569-6580. (doi:10.1128/MCB.24.15.6569-6580.2004) (Pubitemid 38944338)
224. Yang YJ, Song TY, Park J, Lee J, Lim J, Jang H, Kim YN, Yang JH, Song Y, Choi A et al. 2013 Meninmediates epigenetic regulation via histone H3 lysine 9 methylation. Cell Death and Differentiation 4 e583. (doi:10.1038/cddis.2013.98)
225. Yokoyama A & Cleary ML 2008 Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 14 36-46. (doi:10.1016/j.ccr.2008.05.003) (Pubitemid 351885493)
226. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W & Cleary ML 2004 Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Molecular and Cellular Biology 24 5639-5649. (doi:10.1128/MCB.24.13.5639-5649.2004) (Pubitemid 38787950)
227. Yokoyama A, Somervaille T, Smith K, Rozenblatt-Rosen O, Meyerson M & Cleary M 2005 The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123 207-218. (doi:10.1016/j.cell.2005.09.025) (Pubitemid 41457212)
228. Yu F, Venzon DJ, Serrano J, Goebel SU, Doppman JL, Gibril F & Jensen RT 1999 Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. Journal of Clinical Oncology 17 615-630. (Pubitemid 29075250)
229. Zablewska B, Bylund L, Mandic SA, Fromaget M, Gaudray P & Weber G 2003 Transcription regulation of the multiple endocrine neoplasia type 1 gene in human and mouse. Journal of Clinical Endocrinology and Metabolism 88 3845-3851. (doi:10.1210/jc.2003-030288) (Pubitemid 37034537)